Is this small cap in the fast lane to the ASX 300?
In our latest podcast episode, discover why Generation Development Group is IML's stock of the month with Lucas Goode, Portfolio Manager...
In our latest podcast episode, discover why Generation Development Group is IML's stock of the month with Lucas Goode, Portfolio Manager...
In our latest podcast episode, discover insights on ResMed's stock analysis and the impact of Ozempic and GLP-1 drugs with Senior Equity...
AI has easily been the hottest topic in investing this year. While IML's Daniel Moore is excited about its potential, he is cautious of...
Simon Conn and Jason Guthrie discuss how the small-mid cap funds performed during the March quarter 2024 including key...
In our new podcast, Daniel Moore talks to Jason Guthrie about how IML's large-cap funds performed during March quarter...